Samdal F, Brevik B
Department of Surgery, Trondheim University Hospital, Norway.
Scand J Urol Nephrol. 1990;24(3):175-7. doi: 10.3109/00365599009180854.
Laser treatment associated with transurethral resection of the prostate is a new and promising treatment of the stages T0 diffuse, T1 and T2 prostatic cancer. Our standardized treatment procedure gives few complications. So far we have not recorded any local recurrence in the 26 patients we have treated and followed up from 6 to 42 months.
激光治疗联合经尿道前列腺切除术是治疗T0期弥漫性、T1期和T2期前列腺癌的一种新的且有前景的治疗方法。我们的标准化治疗程序并发症较少。到目前为止,在我们治疗并随访了6至42个月的26例患者中,尚未记录到任何局部复发情况。